Dongxing Medical announced that the company plans to use its own capital of 20 million yuan to 40 million yuan to buy back shares for equity incentives or employee stock ownership plans. The repurchase price does not exceed 41.70 yuan/share. It is estimated that 479,700 shares to 9592,000 shares can be repurchased, accounting for 0.48%-0.96% of the total share capital. The repurchase period is within 12 months from the date of review and approval by the board of directors. The buyback has been approved by the board of directors and does not require review by the shareholders' meeting. The company indicated repurchase risks in terms of stock prices, major events, application implementation, and new regulatory regulations.

Dongxing Medical announced that the company plans to use its own capital of 20 million yuan to 40 million yuan to buy back shares for equity incentives or employee stock ownership plans. The repurchase price does not exceed 41.70 yuan/share. It is estimated that 479,700 shares to 9592,000 shares can be repurchased, accounting for 0.48%-0.96% of the total share capital. The repurchase period is within 12 months from the date of review and approval by the board of directors. The buyback has been approved by the board of directors and does not require review by the shareholders' meeting. The company indicated repurchase risks in terms of stock prices, major events, application implementation, and new regulatory regulations.